Delay in administering second dose a threat to Covid vaccine efficacy, says Fauci

Any deviation from schedules that worked in clinical trials creates risks such as the rise of new coronavirus mutations, said Fauci at virtual World Economic Forum panel.

Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci at a Senate hearing (file photo) | Bloomberg

Washington: U.S. infectious-disease chief Anthony Fauci said he’s worried about a push to delay administering the second dose of Covid-19 vaccines to speed immunizations.
Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, said Monday that any deviation from schedules that worked in clinical trials creates risks such as the rise of new coronavirus mutations.

“I’d be concerned, because you don’t get full efficacy until you get that second dose,” Fauci said on a virtual World Economic Forum panel moderated by Bloomberg’s editor in chief, John Micklethwait.

Governments around the world are scrambling to boost vaccination programs to curb the worrisome spread of new variants. France on Saturday recommended doubling the amount of time between the first and second shots, days after the U.S. Centers for Disease Control and Prevention said the follow-up doses could be given up to six weeks later.

The U.K. was first to adopt the controversial approach. Shots made by Pfizer Inc. with BioNTech SE and by Moderna Inc. were designed and tested with two inoculations, 21 or 28 days apart. There are no data to demonstrate that protection from the first dose is sustained after the date of the second injection. Another vaccine, developed by the University of Oxford and AstraZeneca Plc, was tested with broader gaps between the two shots.

The rush to broaden vaccinations to as many as people as possible in the first instance comes amid concern about the new strains. The U.K. has said that one variant that was first identified there could be more contagious as well as deadlier. Another one that’s spreading in South Africa has shown that it may be more resistant to vaccines.

“There seems to be considerable more threat to vaccine efficacy, even though the cushion of efficacy is sound enough that the vaccines we’re using now will be good against both the mutant in South Africa as well as those in the U.K.,” Fauci said.

Vaccine developers need to look at tweaking shots to address the new variants, Fauci said. Researchers and other health officials have said that could generally be done within weeks for many shots.

Fauci has vaulted back onto the international scene since U.S. President Joe Biden’s inauguration last week, speaking to the media about being disparaged under the Trump administration and pledging his country’s renewed commitment to the World Health Organization.

Although it’s important to overhaul the WHO, Fauci said, the revamped organization has an “absolutely critical” role in fighting disease outbreaks.- Bloomberg